Halozyme Therapeutics Inc Net Asset Quality Index
Halozyme Therapeutics Inc net asset quality index. Halozyme Therapeutics Inc (HALO) has a Net Asset Quality Index of 22.7% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $2.22 Billion minus total liabilities of $1.72 Billion yields net assets of $503.92 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check HALO operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Halozyme Therapeutics Inc (2001–2024)
Net asset quality index of Halozyme Therapeutics Inc from 2001 to 2024. This chart shows how Halozyme Therapeutics Inc's Net Asset Quality Index has evolved across 24 annual periods from 2001 to 2024. As of September 2025, the index stands at 22.7%, representing net assets of $503.92 Million against total assets of $2.22 Billion USD. See Halozyme Therapeutics Inc book value and equity for net asset value and shareholders' equity analysis.
Halozyme Therapeutics Inc Net Asset Quality Index by Year (2001–2024)
Halozyme Therapeutics Inc net asset quality index by year from 2001 to 2024. The table below presents the year-by-year Net Asset Quality Index for Halozyme Therapeutics Inc from 2001 to 2024, covering 24 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Halozyme Therapeutics Inc.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 17.6% | $363.82 Million | $2.06 Billion | $1.70 Billion | ▲ +12.8 pp |
| 2023 | 4.8% | $83.81 Million | $1.73 Billion | $1.65 Billion | ▼ -4.4 pp |
| 2022 | 9.2% | $169.80 Million | $1.84 Billion | $1.67 Billion | ▼ -8.6 pp |
| 2021 | 17.8% | $196.95 Million | $1.10 Billion | $907.48 Million | ▼ -8.2 pp |
| 2020 | 26.0% | $151.05 Million | $579.92 Million | $428.88 Million | ▲ +9.8 pp |
| 2019 | 16.2% | $91.77 Million | $565.87 Million | $474.11 Million | ▼ -40.3 pp |
| 2018 | 56.5% | $248.89 Million | $440.25 Million | $191.36 Million | ▲ +16.5 pp |
| 2017 | 40.1% | $208.37 Million | $519.95 Million | $311.58 Million | ▲ +52.5 pp |
| 2016 | -12.4% | $-32.48 Million | $261.51 Million | $294.00 Million | ▼ -36.1 pp |
| 2015 | 23.7% | $43.00 Million | $181.79 Million | $138.79 Million | ▼ -1.3 pp |
| 2014 | 24.9% | $41.35 Million | $165.98 Million | $124.62 Million | ▲ +44.6 pp |
| 2013 | -19.6% | $-19.99 Million | $101.79 Million | $121.78 Million | ▼ -55.9 pp |
| 2012 | 36.3% | $48.85 Million | $134.73 Million | $85.87 Million | ▲ +19.7 pp |
| 2011 | 16.6% | $10.90 Million | $65.76 Million | $54.86 Million | ▼ -5.7 pp |
| 2010 | 22.3% | $20.35 Million | $91.35 Million | $70.99 Million | ▲ +13.3 pp |
| 2009 | 8.9% | $6.90 Million | $77.15 Million | $70.25 Million | ▼ -11.1 pp |
| 2008 | 20.1% | $15.38 Million | $76.56 Million | $61.18 Million | ▼ -35.7 pp |
| 2007 | 55.8% | $57.77 Million | $103.46 Million | $45.69 Million | ▲ +5.8 pp |
| 2006 | 50.1% | $23.08 Million | $46.09 Million | $23.01 Million | ▼ -38.7 pp |
| 2005 | 88.8% | $18.21 Million | $20.51 Million | $2.30 Million | ▼ -1.6 pp |
| 2004 | 90.4% | $14.82 Million | $16.40 Million | $1.58 Million | ▲ +69.2 pp |
| 2003 | 21.2% | $10.06K | $47.52K | $37.45K | ▼ -68.1 pp |
| 2002 | 89.3% | $86.81K | $97.25K | $10.43K | ▲ +1.9 pp |
| 2001 | 87.4% | $22.84K | $26.13K | $3.29K | — |